Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation
Immunology & Cell Biology · 2024-07 · 102 (6) · 513-525
DOI: 10.1111/imcb.12762 ↗At a glance
Journal article in Immunology & Cell Biology, published online on 2024-05-10. Written by Adam Alexandersson and 8 co-authors. Institution: Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland. Major MEDLINE topics: Hematopoietic Stem Cell Transplantation, Proteomics, Cytomegalovirus, Cytomegalovirus Infections. Cited 8 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY 4.0). Funded by: Helsingin Yliopiston Tiedesäätiö, Finska Läkaresällskapet, H2020 European Research Council.
Abstract (original language)
We studied the associations between inflammation‐related proteins in circulation and complications after pediatric allogenic hematopoietic stem cell transplantation (HSCT), to reveal proteomic signatures or individual soluble proteins associated with specific complications after HSCT. We used a proteomics method called Proximity Extension Assay to repeatedly measure 180 different proteins together with clinical variables, cellular immune reconstitution and blood viral copy numbers in 27 children (1–18 years of age) during a 2‐year follow‐up after allogenic HSCT. Protein profile analysis was performed using unsupervised hierarchical clustering and a regression‐based method, while the Bonferroni‐corrected Mann–Whitney U ‐test was used for time point–specific comparison of individual proteins against outcome. At 6 months after allogenic HSCT, we could identify a protein profile pattern associated with occurrence of the complications such as chronic graft‐ versus ‐host disease, viral infections, relapse and death. When protein markers were analyzed separately, the plasma concentration of the inhibitory and cytotoxic T‐cell surface protein FCRL6 (Fc receptor‐like 6) was higher in patients with cytomegalovirus (CMV) viremia [log 2 ‐fold change 1.5 ( P = 0.00099), 2.5 ( P = 0.00035) and 2.2 ( P = 0.045) at time points 6, 12 and 24 months]. Flow cytometry confirmed that FCRL6 expression was higher in innate‐like γδ T cells, indicating that these cells are involved in controlling CMV reactivation in HSCT recipients. In conclusion, the potentially druggable FCRL6 receptor on cytotoxic T cells appears to have a role in controlling CMV viremia after HSCT. Furthermore, our results suggest that system‐level analysis is a useful addition to the studying of single biomarkers in allogenic HSCT.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland.
- Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Children and Adolescents, Pediatric Research Center, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
- Center of Vaccinology, University of Geneva, Geneva, Switzerland.
- Institute of Biomedicine, University of Turku, Turku, Finland.
ORCID profiles: Adam Alexandersson, Mikko S Venäläinen, Nelli Heikkilä, Xiaobo Huang, Mervi Taskinen, Pasi Huttunen, Laura L Elo, Minna Koskenvuo, Eliisa Kekäläinen
Funding
- Helsingin Yliopiston Tiedesäätiö
- Finska Läkaresällskapet
- H2020 European Research Council
- Research Council of Finland
- ELIXIR Finland
- Sigrid Juséliuksen Säätiö
- Biocenter Finland
- European Research Council
Cite
APA
Alexandersson, A., Venäläinen, M. S., Heikkilä, N., Huang, X., Taskinen, M., Huttunen, P., Elo, L. L., Koskenvuo, M., & Kekäläinen, E. (2024). Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation. Immunology & Cell Biology, 102(6), 513-525. https://doi.org/10.1111/imcb.12762
Vancouver
Alexandersson A, Venäläinen MS, Heikkilä N, Huang X, Taskinen M, Huttunen P, et al. Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation. Immunology & Cell Biology. 2024;102(6):513-525. doi:10.1111/imcb.12762
BibTeX
@article{Alexandersson2024,
author = {Alexandersson, Adam and Venäläinen, Mikko S and Heikkilä, Nelli and Huang, Xiaobo and Taskinen, Mervi and Huttunen, Pasi and Elo, Laura L and Koskenvuo, Minna and Kekäläinen, Eliisa},
title = {Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation},
journal = {Immunology & Cell Biology},
year = {2024},
volume = {102},
number = {6},
pages = {513--525},
doi = {10.1111/imcb.12762}
}
EUVIMED